First oral COVID-19 treatments approved

Two drugs have been added to Australia’s arsenal in the fight against COVID-19, to treat people at increased risk of progression to hospitalisation or death The TGA has granted provisional approval of the first oral treatments for COVID-19 in Australia, MSD’s Lagevrio (molnupiravir) and Pfizer’s Paxlovid (nirmatrelvir + ritonavir). Both medicines are to be used